Leap Therapeutics, Inc. has changed its name to Cypherpunk Technologies Inc. effective November 12, 2025, and has entered into a consulting agreement with CoinXit Ltd. to provide consulting services, which includes compensation comprising 2,411,700 restricted stock units (RSUs). The filing also includes details of an employment agreement for Chief Investment Officer William McEvoy, who is set to receive an initial base salary of $250,000 and a grant of 5,616,906 RSUs.